,

Ramanan Laxminarayan1, Isabella Impalli2, Radha Rangarajan3

  • 1One Health Trust, Bengaluru, India; High Meadows Environmental Institute, Princeton University, Princeton, NJ, USA.

PubMed
概括

全球抗生素耐药性感染的增加需要新的药物开发经济模式,重点是公共私营伙伴关系,以确保全球可负担的新型抗生素,疫苗和诊断方法.